In individuals undergoing repeated blood exchanges or transfusions, however, the amount of iron introduced into their bodies ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

No matter what the cause of the spinal disease, making changes around the house can help a lot. Ramps help dogs get up the ...

Doctors say there are easy, inexpensive (or free!) arthritis self-care remedies that can make a world of difference. Odds are ...

Chronic illnesses in dogs often have subtle symptoms that progress over time, making them difficult to spot. In this article, ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

The immune system is our unsung hero when it comes to staying healthy and sickness-free. Without us noticing, it mounts round ...

Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying ...

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

(RTTNews) - Drug maker Bristol-Myers Squibb Co. (BMY) Monday announced positive topline results from two pivotal Phase 3 trials evaluating Sotyktu (deucravacitinib) in adults with active psoriatic ...

Bristol Myers on Monday said the two Phase 3 studies met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving at least a 20% improvement in signs and ...

Ivarmacitinib, a novel Janus kinase 1 inhibitor, may be considered a potential treatment for patients with moderate to severe ...